Sangamo Therapeutics (NASDAQ:SGMO): Q3 GAAP EPS of -$0.24 beats by $0.11.
Revenue of $21.96M (-6.8% Y/Y) beats by $9.8M.
Shares +2%.
Wednesday, November 6, 2019
Fitbit EPS in-line, beats on revenue
Fitbit (NYSE:FIT): Q3 Non-GAAP EPS of -$0.10 in-line; GAAP EPS of -$0.20 misses by $0.03.
Revenue of $347.2M (-11.8% Y/Y) beats by $1.9M.
https://seekingalpha.com/news/3515665-fitbit-eps-line-beats-revenue
Coherus BioSciences EPS beats by $0.10, beats on revenue
Coherus BioSciences (NASDAQ:CHRS): Q3 GAAP EPS of $0.63 beats by $0.10.
Revenue of $111.68M beats by $4.98M.
Shares +3.28%.
Dynavax EPS misses by $0.09, beats on revenue
Dynavax (NASDAQ:DVAX): Q3 GAAP EPS of -$0.49 misses by $0.09.
Revenue of $10.58M (+624.7% Y/Y) beats by $0.27M.
OraSure Technologies EPS beats by $0.12, misses on revenue
OraSure Technologies (NASDAQ:OSUR): Q3 GAAP EPS of $0.21 beats by $0.12.
Revenue of $35.99M (-21.6% Y/Y) misses by $2.63M.
Unity Biotechnology reports Q3 results
Unity Biotechnology (NASDAQ:UBX): Q3 GAAP EPS of -$0.51.
Cash, cash equivalents and investments of $120.3M
Geron EPS beats by $0.07, beats on revenue
Geron (NASDAQ:GERN): Q3 GAAP EPS of -$0.08 beats by $0.07.
Revenue of $0.13M (-23.5% Y/Y) beats by $0.08M.
Subscribe to:
Comments (Atom)